WINTON GROUP Ltd Makes New $7.75 Million Investment in Tenet Healthcare Corporation $THC

Key Points

• WINTON GROUP Ltd opened a new position in Tenet Healthcare, buying 38,161 shares worth about $7.75 million in the third quarter, and institutional investors now own roughly 95.44% of the stock.
• Tenet reported a quarter-beating $4.70 EPS on $5.53 billion revenue (up 8.9% YoY) and issued FY2026 guidance of 16.190–18.470 EPS, while analysts hold a consensus “Moderate Buy” with an average target near $247.67.
• Despite analyst optimism, insiders have been net sellers recently — selling about 34,195 shares valued at roughly $7.91 million over the last three months, leaving insider ownership at about 0.81%.

WINTON GROUP Ltd bought a new position in Tenet Healthcare Corporation (NYSE:THC - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 38,161 shares of the company's stock, valued at approximately $7,748,000.

Several other institutional investors have also recently bought and sold shares of the stock. William B. Walkup & Associates Inc. bought a new stake in shares of Tenet Healthcare during the third quarter worth $32,000. Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare during the 2nd quarter worth $35,000. Westside Investment Management Inc. raised its position in shares of Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company's stock valued at $39,000 after acquiring an additional 96 shares during the last quarter. Trust Co. of Vermont acquired a new stake in shares of Tenet Healthcare in the 3rd quarter valued at approximately $41,000. Finally, True Wealth Design LLC raised its stake in Tenet Healthcare by 238.2% during the 2nd quarter. True Wealth Design LLC now owns 257 shares of the company's stock worth $45,000 after buying an additional 181 shares during the period. Institutional investors own 95.44% of the company's stock.

Tenet Healthcare Stock Performance

Shares of THC stock opened at $236.67 on Monday. The firm has a market cap of $20.58 billion, a PE ratio of 15.28, a P/E/G ratio of 1.17 and a beta of 1.39. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $247.21. The company's fifty day simple moving average is $210.13 and its 200-day simple moving average is $202.43. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.08 by $0.62. The firm had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company's revenue was up 8.9% compared to the same quarter last year. During the same period in the previous year, the business earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities research analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on THC shares. Weiss Ratings upgraded Tenet Healthcare from a "hold (c+)" rating to a "buy (b-)" rating in a report on Monday, December 29th. Morgan Stanley reiterated an "overweight" rating and issued a $260.00 price target on shares of Tenet Healthcare in a report on Thursday, February 12th. JPMorgan Chase & Co. raised their price objective on shares of Tenet Healthcare from $200.00 to $230.00 and gave the stock an "overweight" rating in a report on Thursday, November 13th. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $265.00 target price on shares of Tenet Healthcare in a research note on Monday, February 16th. Finally, Barclays lifted their price target on Tenet Healthcare from $240.00 to $257.00 and gave the company an "overweight" rating in a research note on Friday, February 13th. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $247.67.

Insiders Place Their Bets

In other Tenet Healthcare news, insider R. Scott Ramsey sold 8,017 shares of the company's stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total transaction of $1,865,555.90. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the transaction, the director directly owned 28,480 shares of the company's stock, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 34,195 shares of company stock valued at $7,912,606. 0.81% of the stock is currently owned by corporate insiders.

About Tenet Healthcare

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.